R&D San Diego771235338
08:00 AM PDT

Drug Discovery Biology

Strategy Meeting West Coast USA 2023

Assessing, Choosing And Optimizing The Right Set Of Data And Methodologies To Help With Finding Effective Modalities And Techniques For Drug Discovery Biology

What makes our strategy meetings unique?


Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.


Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.


Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.


Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.


Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.


Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at Drug Discovery Biology strategy meeting.

Steve Smith

Technical Director of in vivo Pharmacology WuXi AppTec

Arun Thottumkara

Director of Chemistry, Enabling Science Odyssey Therapeutics

Beth Hoffman

Founder & CEO Origami Therapeutics

Erik Goka

Vice President, Biology Revere Pharmaceuticals

Kate Blease

Vice President Translational Sciences Pfizer

Han Xu

SVP, Head of Biology Velia Therapeutics

Heather Estrella

Associate Scientific Director Takeda San Diego, Inc.

Leo Kirkovsky

Director Clinical Assay Pfizer

Jack Reich

Chief Executive Officer Renova Therapeutics

Kristy D. Bruse

Sr. Director, Toxicology Ferring Pharmaceuticals

Rishi Rakhit

Vice President, Translational Medicine Mitokinin Inc

Robert T. Fremeau, Jr.

Founder and Chief Scientific Officer Brainstorm Therapeutics, Inc.

Sandor Szalma

Global Head Genetics and Systems Biology, Preclinical and Translational Sciences Takeda

Susan Whitehead

President & Chief Operating Officer PACT Pharma

Tove Tuntland

Global Head, DMPK Ferring Pharmaceuticals

Yuhua Ji

Vice President, Drug Discovery Grace Science, LLC
See the agenda and facilitator line-up. Download the strategy meeting brochure for full details.

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

There’s only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter

Senior Decision Makers

All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Personalised Agendas

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we’ll create a personalised agenda just for you

Private and Intimate Networking

Small group discussions, private meetings, networking drinks – however you choose to make those important connections our Strategy Meetings have the solution


See Which Topics Are Up For Discussion


Roundtable Tracks

Target Identification & Hit Validation Leveraging the Power of Multi-Omics in Drug Discovery: Maximizing the Potential in Target Identification and Safety Profiling DMPK / ADME & Toxicology How to Leverage AI and Clinical Data to Better Predict Toxicology for Future Drug Discovery In Vivo and In Vitro Pharmacology In Vivo and In Vitro Pharmacology Advances to Maximize Preclinical Drug Discovery In Silico Biology Novel Drug Modality Update: RNA-Targeting Small Molecules Strategic Partnerships & Collaborations Drug Development Acceleration through Collaboration and Decentralization of Research and Trials that could Lead to Cost Cutting, Safety and Efficacy Investment, Private Equity Investment, Private Equity & Venture Capital Partnerships Why integrating deep scientific expertise matched with operational and business strategy is key for attracting investment in early stage drug discovery
Become an official strategy meeting partner. Whatever your business needs, we can help. Get in touch for partnering opportunities

Press play to hear what your colleagues had to say…

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team?rnrnJust get in touch and a member of the team will be happy to help.

    I agree to Proventa International storing this information to reply to my query and in accordance with our Privacy Policy.
    You may unsubscribe at any time.